Literature DB >> 19160488

Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression.

Zheng Fu1, Liviu Malureanu, Jun Huang, Wei Wang, Hao Li, Jan M van Deursen, Donald J Tindall, Junjie Chen.   

Abstract

Proper control of entry into and progression through mitosis is essential for normal cell proliferation and the maintenance of genome stability. The mammalian mitotic kinase Polo-like kinase 1 (Plk1) is involved in multiple stages of mitosis5. Here we report that Forkhead Box M1 (FoxM1), a substrate of Plk1, controls a transcriptional programme that mediates Plk1-dependent regulation of cell-cycle progression. The carboxy-terminal domain of FoxM1 binds Plk1, and phosphorylation of two key residues in this domain by Cdk1 is essential for Plk1-FoxM1 interaction. Formation of the Plk1-FoxM1 complex allows for direct phosphorylation of FoxM1 by Plk1 at G2/M and the subsequent activation of FoxM1 activity, which is required for expression of key mitotic regulators, including Plk1 itself. Thus, Plk1-dependent regulation of FoxM1 activity provides a positive-feedback loop ensuring tight regulation of transcriptional networks essential for orderly mitotic progression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19160488      PMCID: PMC2882053          DOI: 10.1038/ncb1767

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  28 in total

Review 1.  Re-staging mitosis: a contemporary view of mitotic progression.

Authors:  J Pines; C L Rieder
Journal:  Nat Cell Biol       Date:  2001-01       Impact factor: 28.824

2.  Plo1(+) regulates gene transcription at the M-G(1) interval during the fission yeast mitotic cell cycle.

Authors:  Mark Anderson; Szu Shien Ng; Vanessa Marchesi; Fiona H MacIver; Frances E Stevens; Tracy Riddell; David M Glover; Iain M Hagan; Christopher J McInerny
Journal:  EMBO J       Date:  2002-11-01       Impact factor: 11.598

3.  Over-expression of FoxM1 stimulates cyclin B1 expression.

Authors:  T W Leung; S S Lin; A C Tsang; C S Tong; J C Ching; W Y Leung; R Gimlich; G G Wong; K M Yao
Journal:  FEBS Lett       Date:  2001-10-19       Impact factor: 4.124

4.  A spindle checkpoint arrest and a cytokinesis failure by the dominant-negative polo-box domain of Plk1 in U-2 OS cells.

Authors:  Yeon-Sun Seong; Keiju Kamijo; Jae-Seon Lee; Ester Fernandez; Ryoko Kuriyama; Toru Miki; Kyung S Lee
Journal:  J Biol Chem       Date:  2002-05-28       Impact factor: 5.157

5.  Functional studies on the role of the C-terminal domain of mammalian polo-like kinase.

Authors:  Young-Joo Jang; Chin-Yo Lin; Sheng Ma; Raymond L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

6.  Proteomic screen finds pSer/pThr-binding domain localizing Plk1 to mitotic substrates.

Authors:  Andrew E H Elia; Lewis C Cantley; Michael B Yaffe
Journal:  Science       Date:  2003-02-21       Impact factor: 47.728

7.  Plk1 promotes nuclear translocation of human Cdc25C during prophase.

Authors:  Fumiko Toyoshima-Morimoto; Eri Taniguchi; Eisuke Nishida
Journal:  EMBO Rep       Date:  2002-03-15       Impact factor: 8.807

8.  Plk phosphorylation regulates the microtubule-stabilizing protein TCTP.

Authors:  Frederic R Yarm
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

Review 9.  The RB and p53 pathways in cancer.

Authors:  Charles J Sherr; Frank McCormick
Journal:  Cancer Cell       Date:  2002-08       Impact factor: 31.743

10.  Phosphorylation of mitotic kinesin-like protein 2 by polo-like kinase 1 is required for cytokinesis.

Authors:  Rüdiger Neef; Christian Preisinger; Josephine Sutcliffe; Robert Kopajtich; Erich A Nigg; Thomas U Mayer; Francis A Barr
Journal:  J Cell Biol       Date:  2003-08-25       Impact factor: 10.539

View more
  181 in total

1.  FoxM1 mediates resistance to herceptin and paclitaxel.

Authors:  Janai R Carr; Hyun Jung Park; Zebin Wang; Megan M Kiefer; Pradip Raychaudhuri
Journal:  Cancer Res       Date:  2010-06-08       Impact factor: 12.701

2.  The MuvB complex sequentially recruits B-Myb and FoxM1 to promote mitotic gene expression.

Authors:  Subhashini Sadasivam; Shenghua Duan; James A DeCaprio
Journal:  Genes Dev       Date:  2012-03-01       Impact factor: 11.361

3.  Cyclin-dependent kinase 8 regulates mitotic commitment in fission yeast.

Authors:  Zsolt Szilagyi; Gabor Banyai; Marcela Davila Lopez; Christopher J McInerny; Claes M Gustafsson
Journal:  Mol Cell Biol       Date:  2012-03-26       Impact factor: 4.272

4.  Checkpoint recovery after DNA damage: a rolling stop for CDKs.

Authors:  Anja M Duursma; Karlene A Cimprich
Journal:  EMBO Rep       Date:  2010-05-14       Impact factor: 8.807

5.  Global phosphoproteome profiling reveals unanticipated networks responsive to cisplatin treatment of embryonic stem cells.

Authors:  Alex Pines; Christian D Kelstrup; Mischa G Vrouwe; Jordi C Puigvert; Dimitris Typas; Branislav Misovic; Anton de Groot; Louise von Stechow; Bob van de Water; Erik H J Danen; Harry Vrieling; Leon H F Mullenders; Jesper V Olsen
Journal:  Mol Cell Biol       Date:  2011-10-17       Impact factor: 4.272

6.  Female infertility in PDE3A(-/-) mice: polo-like kinase 1 (Plk1) may be a target of protein kinase A (PKA) and involved in meiotic arrest of oocytes from PDE3A(-/-) mice.

Authors:  Weixing Shen; Faiyaz Ahmad; Steven Hockman; John Ma; Hitoshi Omi; Nalini Raghavachari; Vincent Manganiello
Journal:  Cell Cycle       Date:  2010-12-01       Impact factor: 4.534

Review 7.  Playing polo during mitosis: PLK1 takes the lead.

Authors:  G Combes; I Alharbi; L G Braga; S Elowe
Journal:  Oncogene       Date:  2017-04-24       Impact factor: 9.867

Review 8.  Beyond cytokinesis: the emerging roles of CEP55 in tumorigenesis.

Authors:  J Jeffery; D Sinha; S Srihari; M Kalimutho; K K Khanna
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

9.  Kinome-wide functional screen identifies role of PLK1 in hormone-independent, ER-positive breast cancer.

Authors:  Neil E Bhola; Valerie M Jansen; Sangeeta Bafna; Jennifer M Giltnane; Justin M Balko; Mónica V Estrada; Ingrid Meszoely; Ingrid Mayer; Vandana Abramson; Fei Ye; Melinda Sanders; Teresa C Dugger; Eliezer V Allen; Carlos L Arteaga
Journal:  Cancer Res       Date:  2014-12-05       Impact factor: 12.701

10.  MEK inhibition increases lapatinib sensitivity via modulation of FOXM1.

Authors:  S S Gayle; R C Castellino; M C Buss; R Nahta
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.